Patents by Inventor Dale Robinson

Dale Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12262961
    Abstract: Surgical robot systems, anatomical structure tracker apparatuses, and US transducer apparatuses are disclosed. A surgical robot system includes a robot, a US transducer, and at least one processor. The robot includes a robot base, a robot arm coupled to the robot base, and an end-effector coupled to the robot arm. The end-effector is configured to guide movement of a surgical instrument. The US transducer is coupled to the end-effector and operative to output US imaging data of anatomical structure proximately located to the end-effector. The least one processor is operative to obtain an image volume for the patient and to track pose of the end-effector relative to anatomical structure captured in the image volume based on the US imaging data.
    Type: Grant
    Filed: December 26, 2023
    Date of Patent: April 1, 2025
    Assignee: Globus Medical, Inc.
    Inventors: Neil Crawford, Paden Troxell, Dale Earle, Michael Robinson, Keiichi Matsuda, Isaac Dulin
  • Patent number: 12263249
    Abstract: The invention provides methods for the preparation of particles including one or more agents, e.g., therapeutic or diagnostic agents. The particles can be formed by creating droplets of a first liquid, e.g., including an agent, and removing the first liquid, e.g., through its dispersal in a second liquid and/or evaporation, to solidify the droplets. Advantageously, the process of forming the particles does not significantly alter the structure or activity of the agents and may enhance the stability of the agents. For example, the particles may be stored for long periods of time without significant loss of activity, and in some embodiments, without the need for refrigeration. These particles may be used to generate stabilized pharmaceutical compositions for storage or other logistical purposes, pharmaceutical suspensions, pharmaceutical powder formulations (e.g., inhalable powders, injectable powders), creams or other topical pastes, nutraceuticals, or cosmetics.
    Type: Grant
    Filed: June 30, 2021
    Date of Patent: April 1, 2025
    Assignee: Elektrofi, Inc.
    Inventors: Chase Spenser Coffman, Lyndon Fitzgerald Charles, Jr., Paul Brown, Daniel Benjamin Dadon, Lisa Liu, Cory Robinson, Dale Arlington Thomas, III
  • Publication number: 20250017685
    Abstract: A surgical robot positions an end effector that guides movement of a surgical tool during a surgical procedure on a patient anatomical structure. A tracking system determines a pose of the anatomical structure and a pose of the end effector and/or the surgical tool. A navigation controller determines a target pose for the surgical tool based on a surgical plan and based on the pose of the anatomical structure, and generates steering information based on the target pose for the surgical tool, the pose of the anatomical structure, and the pose of the surgical tool and/or the end effector. The steering information indicates where the surgical tool and/or the end effector need to be moved. An AR headset controller receives the steering information from the navigation controller and displays a graphical representation of the steering information and/or the target pose for the surgical tool on a see-through display screen.
    Type: Application
    Filed: September 26, 2024
    Publication date: January 16, 2025
    Inventors: Thomas Calloway, Weston Healy, Issac Dulin, Dale Earle, Keiichi Matsuda, Norbert Johnson, Bessam Al Jewad, Christine Russ, Michael Robinson, Keerthighaan Kanagasegar
  • Patent number: 9795607
    Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: October 24, 2017
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
  • Publication number: 20160324861
    Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.
    Type: Application
    Filed: July 21, 2016
    Publication date: November 10, 2016
    Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
  • Patent number: 9428509
    Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: August 30, 2016
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
  • Patent number: 9346812
    Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: May 24, 2016
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
  • Publication number: 20140200206
    Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.
    Type: Application
    Filed: January 15, 2014
    Publication date: July 17, 2014
    Applicant: Signal Pharmaceutical LLC
    Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Mehran Fallah Moghaddam, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning
  • Publication number: 20140200207
    Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.
    Type: Application
    Filed: January 15, 2014
    Publication date: July 17, 2014
    Applicant: Signal Pharmaceutical LLC
    Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Mehran Fallah Moghaddam, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning
  • Patent number: 8009814
    Abstract: Method, system, and computer program product for building a voice prompt menu for a collection of portlets by acquiring a list of portlets, building a voice menu comprising voice menu items to activate each of the portlets, acquiring a portlet profile containing customization information, and adapting the voice menu using the customization information in the portlet profile. The web portlet may define custom characteristics for consideration by the voice aggregator, for instance, in the positions for its menu items in the hierarchy of the voice portal menu.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: August 30, 2011
    Assignee: International Business Machines Corporation
    Inventors: Dale Robinson Hewitt, William John Izard, Matthew James Ponsford, David Seager Renshaw, Samuel Jonathan Smith
  • Publication number: 20090270418
    Abstract: Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure: Wherein Q and R1-R3 are as defined herein, compositions comprising an effective amount of a Pyrazole Pyrazine Amine Compound and methods for treating or preventing inflammatory conditions, immunological conditions, cancer, neurodegenerative diseases, age-related diseases, cardiovascular diseases and metabolic conditions, or conditions treatable or preventable by inhibition of an IKK, or an IKK pathway, comprising administering an effective amount of a Pyrazole Pyrazine Amine Compound to a patient in need thereof.
    Type: Application
    Filed: January 8, 2009
    Publication date: October 29, 2009
    Inventors: Marianne Sloss, Jeffrey McKenna, Won Hyung Yoon, Stephen Norris, Dale Robinson, Jason Parnes, Graziella Shevlin, Paul Erdman, Robert Hilgraf, Ronald Albers, Sayee Hegde, Andrew Wallace, Henry Chan, Loui Madakamutil, Heather Raymon
  • Publication number: 20060030624
    Abstract: Prenylating enzymes are involved in modifying oncoproteins, such as RAS, so that growth of neoplastic cells becomes uncontrolled. Inactivation of such enzymes can prevent uncontrolled growth. ?-Dicarbonyl compounds can be used to covalently modify and thereby inactivate prenylating enzymes such as protein farnesyltransferase and protein geranylgeranyltransferase. The compounds can be designed to enhance affinity and/or specificity for a particular protein substrate.
    Type: Application
    Filed: October 11, 2005
    Publication date: February 9, 2006
    Applicant: Arizona Disease Control Research Commission
    Inventors: Seth Rose, Steven Ottersberg, Karl Okolotowicz, Dale Robinson, Rosemarie Hartman, Scott Lefler
  • Publication number: 20060030603
    Abstract: Antibacterial compounds are described herein having either formula (I) or formula (II): wherein R1A, R1B, R1C, R1D, X, Z, Q, R2A, R2B, R2C and R2D are as defined herein. Compositions comprising compounds of formulas (I) and (II) are also provided.
    Type: Application
    Filed: August 5, 2004
    Publication date: February 9, 2006
    Inventors: Punit Seth, Dale Robinson, Elizabeth Jefferson, Eric Swayze
  • Publication number: 20050032805
    Abstract: Provided are antibacterial biaryl compounds having micromolar MIC activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain.
    Type: Application
    Filed: August 9, 2004
    Publication date: February 10, 2005
    Inventors: Elizabeth Jefferson, Eric Swayze, Punit Seth, Dale Robinson
  • Patent number: 6708195
    Abstract: In a multi-user environment, a method of controlling access to objects is required, such that updates performed by one user are not overwritten by simultaneous updates by another user. There is provided a method of controlling access to objects and containers, each representing a group of objects, in a multi-user environment whereby lock states of the objects and lock states of the containers are stored in a computer system, said method comprising the steps of: accepting a request for access to an object or a container; deciding access based on the lock state for that object or container, the lock state of a container if the request is for an object contained within that container, and the lock state of objects grouped within a container if the request is for a container object; and sending a message to the requester granting or denying access to said object or container object. Updates performed by one user on an object or a container are not overwritten by simultaneous updates by another user.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: March 16, 2004
    Assignee: International Business Machines Corporation
    Inventors: Samuel David Borman, Kevin Patrick Corrigan, Dale Robinson Hewitt
  • Patent number: 6400807
    Abstract: A system for developing and testing a telephony application on a interactive voice system without using associated telephony hardware. The telephony application normally sends and receives hardware signals to and from the system telephony hardware for communication with a telephone. In this invention a telephony emulator intercepts the hardware signals from the voice application and sends back simulated hardware signals to the voice application. A graphical user interface provides the user output in response to the telephony emulator means and accepts and passes on user input to the emulator means.
    Type: Grant
    Filed: February 10, 1999
    Date of Patent: June 4, 2002
    Assignee: International Business Machines Corporation
    Inventors: Dale Robinson Hewitt, Philip R L Taunton
  • Publication number: 20010044437
    Abstract: Disclosed are methods of reducing serum uric acid levels, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of gout and related diseases. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: January 11, 2001
    Publication date: November 22, 2001
    Inventors: Dale Robinson, Marcele Boyd
  • Patent number: 4181991
    Abstract: An improved mattress foundation particularly suited for use with foam mattresses to provide proper support for the mattress and to duplicate the feel of box springs. The mattress foundation utilizes an upper and lower frame assembly separated by a flexible, resilient material, which may be in the form of blocks, strips or slabs of flexible, resilient material, with the upper frame assembly preferably being somewhat flexible so as to be capable of deforming from its normal planar condition when subjected to more concentrated loads. The material separating the upper and lower frame assemblies are selected to have a resilience which will support the weight of one or two persons while distributed over the mattress foundation without substantial deflection, but which will deflect significantly when subjected to an individual's weight in more concentrated form, such as occurs when an individual sits on the edge of a bed or is getting into or out of the bed.
    Type: Grant
    Filed: February 9, 1978
    Date of Patent: January 8, 1980
    Assignee: United Foam Corporation
    Inventors: Charles W. Morgan, Dale Robinson, Farouk Farag